These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 11469860)

  • 1. Ketoconazole-induced conformational changes in the active site of cytochrome P450eryF.
    Cupp-Vickery JR; Garcia C; Hofacre A; McGee-Estrada K
    J Mol Biol; 2001 Aug; 311(1):101-10. PubMed ID: 11469860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of cytochrome P450eryF: substrate, inhibitors, and model compounds bound in the active site.
    Cupp-Vickery JR; Poulos TL
    Steroids; 1997 Jan; 62(1):112-6. PubMed ID: 9029724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7-Benzyloxyquinoline oxidation by P450eryF A245T: finding of a new fluorescent substrate probe.
    Khan KK; Halpert JR
    Chem Res Toxicol; 2002 Jun; 15(6):806-14. PubMed ID: 12067248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108.
    de Groot MJ; Vermeulen NP; Kramer JD; van Acker FA; Donné-Op den Kelder GM
    Chem Res Toxicol; 1996; 9(7):1079-91. PubMed ID: 8902262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding.
    Modi S; Paine MJ; Sutcliffe MJ; Lian LY; Primrose WU; Wolf CR; Roberts GC
    Biochemistry; 1996 Apr; 35(14):4540-50. PubMed ID: 8605204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do substrates enter and products exit the buried active site of cytochrome P450cam? 1. Random expulsion molecular dynamics investigation of ligand access channels and mechanisms.
    Lüdemann SK; Lounnas V; Wade RC
    J Mol Biol; 2000 Nov; 303(5):797-811. PubMed ID: 11061976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of the ferrous dioxygen complex of wild-type cytochrome P450eryF and its mutants, A245S and A245T: investigation of the proton transfer system in P450eryF.
    Nagano S; Cupp-Vickery JR; Poulos TL
    J Biol Chem; 2005 Jun; 280(23):22102-7. PubMed ID: 15824115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3.
    Noble MA; Quaroni L; Chumanov GD; Turner KL; Chapman SK; Hanzlik RP; Munro AW
    Biochemistry; 1998 Nov; 37(45):15799-807. PubMed ID: 9843385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azole drugs trap cytochrome P450 EryK in alternative conformational states.
    Montemiglio LC; Gianni S; Vallone B; Savino C
    Biochemistry; 2010 Nov; 49(43):9199-206. PubMed ID: 20845962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active site analysis of P450 enzymes: comparative magnetic circular dichroism spectroscopy.
    Andersson LA; Johnson AK; Peterson JA
    Arch Biochem Biophys; 1997 Sep; 345(1):79-87. PubMed ID: 9281314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric mechanisms in P450eryF probed with 1-pyrenebutanol, a novel fluorescent substrate.
    Davydov DR; Kumar S; Halpert JR
    Biochem Biophys Res Commun; 2002 Jun; 294(4):806-12. PubMed ID: 12061778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the mechanism of biological methane formation: structural evidence for conformational changes in methyl-coenzyme M reductase upon substrate binding.
    Grabarse W; Mahlert F; Duin EC; Goubeaud M; Shima S; Thauer RK; Lamzin V; Ermler U
    J Mol Biol; 2001 May; 309(1):315-30. PubMed ID: 11491299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational dynamics in cytochrome P450-substrate interactions.
    Li H; Poulos TL
    Biochimie; 1996; 78(8-9):695-9. PubMed ID: 9010597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of ligand complexes of P450eryF exhibiting homotropic cooperativity.
    Cupp-Vickery J; Anderson R; Hatziris Z
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3050-5. PubMed ID: 10716705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary crystallographic analysis of an enzyme involved in erythromycin biosynthesis: cytochrome P450eryF.
    Cupp-Vickery JR; Li H; Poulos TL
    Proteins; 1994 Oct; 20(2):197-201. PubMed ID: 7846029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of inhibitor-bound P450BM-3 reveals open conformation of substrate access channel.
    Haines DC; Chen B; Tomchick DR; Bondlela M; Hegde A; Machius M; Peterson JA
    Biochemistry; 2008 Mar; 47(12):3662-70. PubMed ID: 18298086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active site structure and substrate specificity of cytochrome P450 4A1: steric control of ligand approach perpendicular to heme plane.
    Bambal RB; Hanzlik RP
    Biochem Biophys Res Commun; 1996 Feb; 219(2):445-9. PubMed ID: 8605007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of binding modes for ligands in the cytochromes P450 and other heme-containing proteins.
    Kirton SB; Murray CW; Verdonk ML; Taylor RD
    Proteins; 2005 Mar; 58(4):836-44. PubMed ID: 15651036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of CYP199A2, a para-substituted benzoic acid oxidizing cytochrome P450 from Rhodopseudomonas palustris.
    Bell SG; Xu F; Forward I; Bartlam M; Rao Z; Wong LL
    J Mol Biol; 2008 Nov; 383(3):561-74. PubMed ID: 18762195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.